The Clorox Company (CLX) continues to attract attention in the market with various developments. Notably,
Bridgewater Associates LP and
BNP Paribas Financial Markets have reduced their stake while
Natixis Advisors LLC and
Mizuho Securities USA LLC have increased theirs. Meanwhile,
The Clorox Company hit a
52-week high, exhibiting strong momentum. The company has also announced new board members, including Stephen Bratspies and Pierre Breber. Corporate social responsibility efforts are also commendable with major strides in youth development and social justice programs, as well as a partnership with M2030 to advance supply chain climate action.
Clorox has declared regular quarterly dividends multiple times recently, maintaining robust shareholder returns. Increasing quarterly dividends to $1.22 per share, the firm maintains a bright financial outlook. Further, the company completed the planned divestiture of its Better Health VMS Business, setting robust operational goals. Clorox has been named 2024 Safer Choice Partner of the Year by the EPA, highlighting its commitment to ingredient product safety. By slash carbon emissions, Clorox targets net-zero by 2050.
The CLX stock is marked as a solid investment with a profitability rank of 8 as of September 2024.
Clorox Company CLX News Analytics from Thu, 22 Feb 2024 08:00:00 GMT to Sat, 30 Nov 2024 10:37:34 GMT -
Rating 8
- Innovation 7
- Information 9
- Rumor -4
